Raymond Tabibiazar,Amato J. Giaccia,Mihalis Kariolis,Yu Rebecca Miao
申请号:
US15535995
公开号:
US20180057898A1
申请日:
2015.12.17
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Compositions and methods are provided for treating fibrosis in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits AXL, MER or Tyro3 protein activity, for example by inhibition of the binding interaction between AXL, MER or Tyro3 and its ligand GAS6.